ArticleCancers2021

Beta 2 Adrenergic Receptor Antagonist Propranolol and Opioidergic Receptor Antagonist Naltrexone Produce Synergistic Effects on Breast Cancer Growth Prevention by Acting on Cancer Cells and Immune Environment in a Preclinical Model of Breast Cancer.

Sengottuvelan Murugan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.